NKG2D and cytotoxic effector function in tumor immune surveillance

被引:82
作者
Hayakawa, Yoshihiro [1 ]
Smyth, Mark J. [1 ]
机构
[1] Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia
基金
英国医学研究理事会;
关键词
natural killer; cytotoxicity; NKG2D; perforin; cancer;
D O I
10.1016/j.smim.2006.03.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NKG2D is a type II transmembrane-anchored glycoprotein expressed as a disulfide-linked homodimer on the surface of all mouse and human natural killer cells (NK cells). Stimulation of NK cells through NKG2D triggers cell-mediated cytotoxicity and in some cases induces the production of cytokines. NKG2D binds to family of ligands with structural homology to MHC class I, however, unlike conventional MHC class I molecules, NKG2D ligands often display up-regulated surface expression on stressed cells and are frequently over expressed by tumors. Recent evidence clearly implicates that NKG2D recognition plays an important role in tumor immune surveillance and that NKG2D primarily acts to trigger perforin-mediated apoptosis. The data begin to place the NKG2D pathway into the context of other recognition-effector systems used by NK cells. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 105 条
[71]   Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization [J].
Shi, LF ;
Mai, S ;
Israels, S ;
Browne, K ;
Trapani, JA ;
Greenberg, AH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :855-866
[72]   Molecular identification of a danger signal that alerts the immune system to dying cells [J].
Shi, Y ;
Evans, JE ;
Rock, KL .
NATURE, 2003, 425 (6957) :516-521
[73]   NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer [J].
Smyth, MJ ;
Swann, J ;
Kelly, JM ;
Cretney, E ;
Yokoyama, WM ;
Diefenbach, A ;
Sayers, TJ ;
Hayakawa, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (10) :1325-1335
[74]   Activation of NK cell cytotoxicity [J].
Smyth, MJ ;
Cretney, E ;
Kelly, JM ;
Westwood, JA ;
Street, SEA ;
Yagita, H ;
Takeda, K ;
van Dommelen, SLH ;
Degli-Espostic, MA ;
Hayakawa, Y .
MOLECULAR IMMUNOLOGY, 2005, 42 (04) :501-510
[75]   Cytokines in cancer immunity and immunotherapy [J].
Smyth, MJ ;
Cretney, E ;
Kershaw, MH ;
Hayakawa, Y .
IMMUNOLOGICAL REVIEWS, 2004, 202 :275-293
[76]   The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent [J].
Smyth, MJ ;
Taniguchi, M ;
Street, SEA .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2665-2670
[77]   New aspects of natural-killer-cell surveillance and therapy of cancer [J].
Smyth, MJ ;
Hayakawa, Y ;
Takeda, K ;
Yagita, H .
NATURE REVIEWS CANCER, 2002, 2 (11) :850-861
[78]  
Smyth MJ, 1999, J IMMUNOL, V162, P6658
[79]   NKG2D function protects the host from tumor initiation [J].
Smyth, MJ ;
Swann, J ;
Cretney, E ;
Zerafa, N ;
Yokoyama, WM ;
Hayakawa, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05) :583-588
[80]   A fresh look at tumor immunosurveillance and immunotherapy [J].
Smyth, MJ ;
Godfrey, DI ;
Trapani, JA .
NATURE IMMUNOLOGY, 2001, 2 (04) :293-299